Regulation of the 26S proteasome by adenovirus E1A

EMBO Journal

Volumn 19, Issue 17, 2000, Pages 4759-4773

  Turnell, Andrew S ^a   Grand, Roger J A ^a   Gorbea, Carlos ^b   Zhang, Xian ^a   Wang, Wenlan ^c   Mymryk, Joe S ^d   Gallimore, Phillip H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Adenovirus E1A; P53; Proteasome; S4 Sugl (S8)

Indexed keywords

PROTEASOME;

ADENOVIRUS; ARTICLE; CELL CYCLE S PHASE; COMPLEX FORMATION; DELETION MUTANT; ENZYME REGULATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALIGNANT TRANSFORMATION; MEDIATOR RELEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION;

EID: 0034282565     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.17.4759     Document Type: Article

References (69)

1. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
2. Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits. Possible roles in RNA binding and macromolecular assembly
3. The CBP co-activator is a histone acetyltransferase
4. The proteasome: Paradigm of a self-compartmentalizing protease
5. Adenovirus E1A proteins and transformation
6. Mammalian Srb mediator complex is targeted by adenovirus E1A
7. The ubiquitin-proteasome pathway: On protein death and cell life
8. Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin carder protein - E2
9. p300 Binding by E1A cosegregates with p53 induction but is dispensable for apoptosis
10. Degradation of ornithine decarboxylase
11. Degradation of p53 can be targeted by HPV E6 sequences distinct to those required for p53 binding and transactivation
12. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
13. E1A signalling to p53 involves the p19ARF tumor suppressor
14. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kDa protein (p300) reveals a protein with properties of a transcriptional adaptor
15. The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2
16. Sugl, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase
17. Adenovirus genes involved in transformation. What determines the oncogenic phenotype?
18. The zinc finger region of the adenovirus E1A transactivating domain complexes with the TaTa box binding protein
19. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3
20. Mapping subunit contacts in the regulatory complex of the 26S proteasome
21. Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit
22. Enhanced expression of p53 in human cells infected with mutant adenoviruses
23. Control of p53 expression by adenovirus 12 early region 1A and early region 1B 54K proteins
24. Regeneration of the binding properties of adenovirus 12 early region 1A proteins after preparation under denaturing conditions
25. Human cells arrest in S phase in response to adenovirus 12 E1A
26. Adenovirus early region 1A protein binds to mammalian Sugl a regulatory component of the proteasome
27. Mdm2 promotes the rapid degradation of p53
28. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
29. Oncoprotein Mdm2 is a ubiquitin ligase E3 for tumor suppressor p53
30. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A
31. Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26S proteasome
32. Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen
33. Transcriptional modulation by the adenovirus E1A gene
34. Regulation of p53 stability by Mdm2
35. Interaction of thyroid hormone receptor with a conserved transcriptional mediator
36. p53, The cellular gatekeeper for growth and division
37. The adenovirus E1A-associated 130kDa-protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E
38. Promoter targeting by adenovirus E1A through interaction with different cellular DNA-binding domains
39. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
40. Chemical inhibitors of cyclin-dependent kinases
41. The transcriptional coactivators p300 and CBP are histone acetyltransferases
42. The AAA team: Related ATPases with diverse functions
43. Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis
44. Adenovirus E1A 12S protein induces DNA synthesis and proliferation in primary epithelial cells in both the absence and presence of serum
45. Specific interactions between ATPase subunits of the 26S protease
46. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis
47. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
48. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins
49. Identification of the gal4 suppressor Sugl as a subunit of the yeast 26S proteasome
50. Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome
51. Essential role for p53-mediated transcription in E1A-induced apoptosis
52. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in the negative modulation of oncogenic transformation
53. The E6 oncoprotein encoded by HPV type-16 and type-18 promotes the degradation of p53
54. A novel protein complex involved in signal transduction possessing: Similarities to 26S proteasome subunits
55. Organic extraction of Pi with isobutanol/toluene
56. Proteasomal turnover of p21(CIP1) does not require p21(CIP1) ubiquitination
57. Adenovirodae: The viruses and their replication
58. The degradation sequence of adenovirus E1A consists of the amino-terminal tetrapeptide Met-Arg-His-Ile
59. Rapid intracellular turnover of adenovirus 5 early region 1A proteins
60. The large E1B protein together with the E4ORF6 protein target p53 for active degradation in adenovirus infected cells
61. A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein
62. The role of the E6-p53 interaction in the molecular pathogenesis of HPV
63. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
64. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27(KipI)
65. Differential ligand-dependent interactions between AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
66. Identification of specific adenovirus-E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth
67. Mammalian Sugl and c-Fos in the nuclear 26S proteasome
68. Association between oncogene and anti-oncogene: The adenovirus E1A protein binds to the retinoblastoma gene product
69. AAA-ATPase at the crossroads of protein life and cell death